| Without (n = 1518) | With AF (n = 167) | P value |
---|---|---|---|
Sex | Â | Â | 0.505 |
Female | 641 (42.23%) | 75 (44.91%) | Â |
Male | 877 (57.77%) | 92 (55.09%) | Â |
Age (years) | 63.50 (58.00–70.00) | 69.00 (63.00–77.00) | < 0.001* |
BMI (kg/m2) | 25.39 (23.23–27.68) | 25.69 (23.44–27.68) | 0.872 |
CAD type | Â | Â | Â |
SCAD | 70 (4.61%) | 52 (31.14%) | < 0.001* |
UA | 1132 (74.57%) | 86 (51.50%) | < 0.001* |
NSTEMI | 225 (14.82%) | 17 (10.18%) | 0.104 |
STEMI | 71 (4.68%) | 2 (1.20%) | 0.036* |
Previous MI | 166 (10.94%) | 29 (17.37%) | 0.014* |
Ischaemic cardiomyopathy | 24 (1.58%) | 10 (5.99%) | < 0.001* |
Heart failure | 211 (13.90%) | 89 (53.29%) | < 0.001* |
Hypertension | 1041 (68.58%) | 120 (71.86%) | 0.385 |
Dyslipidaemia | 456 (30.04%) | 52 (31.14%) | 0.769 |
Total cholesterol (mmol/L) | 4.00 (3.39–4.70) | 3.83 (3.28–4.70) | 0.229 |
LDL-C (mmol/L) | 2.52 (1.91–3.12) | 2.32 (1.88–3.09) | 0.301 |
Valvular heart disease | 29 (1.91%) | 11 (6.59%) | < 0.001* |
DM | 430 (28.33%) | 50 (29.94%) | 0.661 |
COPD | 35 (2.31%) | 2 (1.20%) | 0.354 |
CKD | 28 (1.84%) | 8 (4.79%) | 0.012* |
Creatine (μmol/L) | 69.00 (59.00–81.00) | 79.85 (68.00–94.75) | < 0.001* |
Fatty liver | 33 (2.17%) | 2 (1.20%) | 0.401 |
Smoking | 296 (19.50%) | 21 (12.57%) | 0.03* |
Alcohol consumption | 249 (16.40%) | 21 (12.57%) | 0.201 |
Aortic atherosclerosis | 458 (30.53%) | 74 (44.58%) | < 0.001* |
LA (mm) | 34.00 (32.00–36.00) | 38.00 (35.00–42.50) | < 0.001* |
EF (%) | 61.74 (60.64–62.89) | 60.78 (55.48–62.05) | 0.001* |
PWV (cm/s) | 1565.00 (1387.75–1810.75) | 1734.75 (1505.88–2149.62) | < 0.001* |
ABI | 1.08 (1.00–1.16) | 1.06 (0.94–1.14) | 0.004* |
CHA2DS2-VASc score | 3.00 (2.00–4.00) | 4.00 (3.00–6.00) | < 0.001* |
Stroke | 289 (19.04%) | 48 (28.74%) | 0.003* |